Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 12 de 12
Filtre
2.
Rev. Assoc. Med. Bras. (1992) ; 63(3): 284-289, Mar. 2017. tab
Article Dans Anglais | LILACS | ID: biblio-956432

Résumé

Summary Objective: In liver diseases, hyperferritinemia (HYF) is related to injured cells in acquired and genetic conditions with or without iron overload. It is frequent in patients with nonalcoholic fatty liver disease (NAFLD), in which it is necessary to define the mean of HYF to establish the better approach for them. The present study evaluated the significance of elevated ferritin in patients with NAFLD and steatohepatitis (NASH). Method: The review was performed using search instruments of indexed scientific material, including MEDLINE (by PubMed), Web of Science, IBECS and LILACS, to identify articles published in Portuguese, English and Spanish, from 2005 to May, 2016. Studies eligible included place and year of publication, diagnose criteria to NAFLD, specifications of serum ferritin measurements and/or liver histopathologic study. Exclusion criteria included studies with patients with alcohol consumption ≥ 20 g/day and other liver diseases. Results: A total of 11 from 30 articles were selected. It included 3,564 patients and they were cross-sectional, retrospective, case series and case-control. The result's analyses showed in 10 of these studies a relationship between ferritin elevated serum levels and NAFLD/NASH with and without fibrosis and insulin resistance. Conclusion: Hyperferritinemia in patients with NAFLD/NASH is associated more frequently with hepatocellular injury than hemochromatosis. These data suggest the relevance to evaluate carefully HYF in patients with NAFLD/NASH to establish appropriate clinical approach.


Resumo Objetivo: A hiperferritinemia (HPF) está associada à agressão hepatocelular nas doenças do fígado e à sobrecarga de ferro, em doenças genéticas e adquiridas. A HPF é frequente em pacientes com doença hepática gordurosa não alcoólica (DHGNA) e é necessário definir seu significado para estabelecer as melhores condutas para esses indivíduos. Esta revisão avaliou o significado da HPF em portadores de DHGNA e esteato-hepatite não alcoólica (EHNA). Método: A busca de artigos foi realizada através do PubMed (Medline), Web of Science e Lilacs, e foram selecionados aqueles publicados em português, inglês e espanhol de 2005 a maio de 2016. Os artigos foram elegíveis quando informavam data e local da publicação, critérios diagnósticos para DHGNA, especificações das dosagens de ferritina sérica e/ou estudo histopatológico. Foram excluídos os artigos cujos pacientes relataram ingestão alcoólica ≥ 20 g/dia ou eram portadores de outras doenças do fígado. Resultados: Foram selecionados 11 de 30 artigos, totalizando 3.564 pacientes. Os artigos eram de corte transversal, retrospectivos, série de casos e caso-controles. Em dez artigos, observou-se correlação entre alteração de ferritina e DHGNA/EHNA com e sem fibrose hepática e resistência à insulina. Conclusão: Hiperferritinemia em pacientes com DHGNA/EHNA se associa com maior frequência à agressão hepatocelular do que com sobrecarga de ferro hepático. Os resultados da revisão sugerem a necessidade de um maior cuidado na interpretação da elevação da ferritina sérica em pacientes com DHGNA/EHNA para o estabelecimento de condutas clínicas apropriadas.


Sujets)
Humains , Surcharge en fer/étiologie , Surcharge en fer/sang , Ferritines/sang , Stéatose hépatique non alcoolique/complications , Stéatose hépatique non alcoolique/sang , Facteurs de risque , Surcharge en fer/anatomopathologie , Stéatose hépatique non alcoolique/anatomopathologie , Fer/sang
3.
Einstein (Säo Paulo) ; 11(4): 528-532, out.-dez. 2013. ilus, tab
Article Dans Portugais | LILACS | ID: lil-699869

Résumé

Relatar um caso de sobrecarga de ferro secundária à xerocitose, uma doença rara, em uma adolescente, diagnosticada por meio de ressonância magnética em T2*. Relatamos o caso de uma paciente sintomática com xerocitose, nível de ferritina de 350ng/mL e sobrecarga de ferro cardíaca significativa. Ela foi diagnosticada por ressonância magnética em T2* e recebeu terapia de quelação. Análise por ectacitometria confirmou o diagnóstico de xerocitose hereditária. Na sequência, a ressonância magnética em T2* demonstrou resolução completa da sobrecarga de ferro em vários órgãos e novo ecocardiograma revelou resolução completa das alterações cardíacas anteriores. A paciente permanece em terapia de quelação. Xerocitose é uma desordem genética autossômica dominante rara, caracterizada por estomatocitose desidratada. O paciente pode apresentar fadiga intensa e sobrecarga de ferro. Sugerimos o uso regular de ressonância magnética em T2* para o diagnóstico e controle da resposta à quelação de ferro em xerocitose e acreditamos que o exame pode ser útil também em outras anemias hemolíticas que necessitam de transfusões.


To report a case of iron overload secondary to xerocytosis, a rare disease in a teenager, diagnosed, by T2* magnetic resonance imaging. We report the case of a symptomatic patient with xerocytosis, a ferritin level of 350ng/mL and a significant cardiac iron overload. She was diagnosed by T2* magnetic resonance imaging and received chelation therapy Ektacytometric analysis confirmed the diagnosis of hereditary xerocytosis. Subsequent T2* magnetic resonance imaging demonstrated complete resolution of the iron overload in various organs, as a new echocardiography revealed a complete resolution of previous cardiac alterations. The patient remains in chelation therapy. Xerocytosis is a rare autosomal dominant genetic disorder characterized by dehydrated stomatocytosis. The patient may present with intense fatigue and iron overload. We suggest the regular use of T2* magnetic resonance imaging for the diagnosis and control of the response to iron chelation in xerocytosis, and we believe it can be used also in other hemolytic anemia requiring transfusions.


Sujets)
Adolescent , Femelle , Humains , Anémie hémolytique congénitale/diagnostic , Anasarque foetoplacentaire/diagnostic , Surcharge en fer/diagnostic , Anémie hémolytique congénitale/complications , Anémie hémolytique congénitale/traitement médicamenteux , Traitement chélateur , Déferoxamine/usage thérapeutique , Anasarque foetoplacentaire/traitement médicamenteux , Surcharge en fer/traitement médicamenteux , Surcharge en fer/étiologie , Imagerie par résonance magnétique , Sidérophores/usage thérapeutique
4.
Journal of Korean Medical Science ; : 363-369, 2012.
Article Dans Anglais | WPRIM | ID: wpr-143930

Résumé

Multiple RBC transfusions inevitably lead to a state of iron overload before and after high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT). Nonetheless, iron status during post-SCT follow-up remains unknown. Therefore, we investigated post-SCT ferritin levels, factors contributing to its sustained levels, and organ functions affected by iron overload in 49 children with high-risk neuroblastoma who underwent tandem HDCT/autoSCT. Although serum ferritin levels gradually decreased during post-SCT follow-up, 47.7% of the patients maintained ferritin levels above 1,000 ng/mL at 1 yr after the second HDCT/autoSCT. These patients had higher serum creatinine (0.62 vs 0.47 mg/mL, P = 0.007) than their counterparts (< 1,000 ng/mL). Post-SCT transfusion amount corresponded to increased ferritin levels at 1 yr after the second HDCT/autoSCT (P < 0.001). A lower CD34+ cell count was associated with a greater need of RBC transfusion, which in turn led to a higher serum ferritin level at 1 yr after HDCT/autoSCT. The number of CD34+ cells transplanted was an independent factor for ferritin levels at 1 yr after the second HDCT/autoSCT (P = 0.019). Consequently, CD34+ cells should be transplanted as many as possible to prevent the sustained iron overload after tandem HDCT/autoSCT and consequent adverse effects.


Sujets)
Enfant , Enfant d'âge préscolaire , Humains , Nourrisson , Antigènes CD34/métabolisme , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Benzoates/usage thérapeutique , Transfusion sanguine/effets indésirables , Créatinine/sang , Ferritines/sang , Études de suivi , Agents chélateurs du fer/usage thérapeutique , Surcharge en fer/étiologie , Neuroblastome/traitement médicamenteux , Études rétrospectives , Facteurs de risque , Transplantation de cellules souches , Transplantation autologue , Triazoles/usage thérapeutique
5.
Journal of Korean Medical Science ; : 363-369, 2012.
Article Dans Anglais | WPRIM | ID: wpr-143923

Résumé

Multiple RBC transfusions inevitably lead to a state of iron overload before and after high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT). Nonetheless, iron status during post-SCT follow-up remains unknown. Therefore, we investigated post-SCT ferritin levels, factors contributing to its sustained levels, and organ functions affected by iron overload in 49 children with high-risk neuroblastoma who underwent tandem HDCT/autoSCT. Although serum ferritin levels gradually decreased during post-SCT follow-up, 47.7% of the patients maintained ferritin levels above 1,000 ng/mL at 1 yr after the second HDCT/autoSCT. These patients had higher serum creatinine (0.62 vs 0.47 mg/mL, P = 0.007) than their counterparts (< 1,000 ng/mL). Post-SCT transfusion amount corresponded to increased ferritin levels at 1 yr after the second HDCT/autoSCT (P < 0.001). A lower CD34+ cell count was associated with a greater need of RBC transfusion, which in turn led to a higher serum ferritin level at 1 yr after HDCT/autoSCT. The number of CD34+ cells transplanted was an independent factor for ferritin levels at 1 yr after the second HDCT/autoSCT (P = 0.019). Consequently, CD34+ cells should be transplanted as many as possible to prevent the sustained iron overload after tandem HDCT/autoSCT and consequent adverse effects.


Sujets)
Enfant , Enfant d'âge préscolaire , Humains , Nourrisson , Antigènes CD34/métabolisme , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Benzoates/usage thérapeutique , Transfusion sanguine/effets indésirables , Créatinine/sang , Ferritines/sang , Études de suivi , Agents chélateurs du fer/usage thérapeutique , Surcharge en fer/étiologie , Neuroblastome/traitement médicamenteux , Études rétrospectives , Facteurs de risque , Transplantation de cellules souches , Transplantation autologue , Triazoles/usage thérapeutique
6.
JPC-Journal of Pediatric Club [The]. 2008; 8 (1): 42-50
Dans Anglais | IMEMR | ID: emr-88444

Résumé

Thalassemias are a group of inherited blood disorders with defective production of hemoglobin. Patients with beta-thalassemia develop iron overload due to increased iron absorption and transfusion therapy. Hepcidin is a hepatic hormone released in case of iron overload to regulate systemic iron homeostasis by inhibiting iron absorption from diet and recycling of iron by macrophages. To determine role of hepcidin in the pathogenesis of iron overload in 6-thalassemia. 20 Patients with beta thalassemia major [TM] included 10 males and 10 females, 20 patients with beta thalassemia intermedia [TI] included 10 males and 10 females and twenty healthy children of matched age and sex were included in this study. We assessed iron overload by measuring serum ferritin, assessed erythropoietic activity by measuring serum erythropoietin levels, and correlated these with urinary hepcidin measurements. We found severe urinary hepcidin deficiency in TI with strong inverse relationship between urinary hepcidin and serum erythropoietin levels in comparison with control group. In contrast, urinary hepcidin levels were elevated in TM with decrease of erythropoietin levels. In addition, serum ferritin level was significantly higher in TM than TI and significantly higher in TM and TI compared with normal control. Hepcidin deficiency may be the key factor allowing excessive iron absorption and iron overload in TI while in TM, chronic hemolysis and frequent blood transfusions may be the main factors that increase iron load


Sujets)
Humains , Mâle , Femelle , Surcharge en fer/étiologie , Ferritines , Érythropoïétine/sang , Peptides antimicrobiens cationiques/urine
7.
Annals of Saudi Medicine. 2008; 28 (5): 361-366
Dans Anglais | IMEMR | ID: emr-94423

Résumé

Iron overload is a major problem in patients with beta-thalassemia major, and it has many structural and metabolic consequences. The aim of this study was evaluation of endocrine distturbances in patients with beta-thalassemia major who were older than 10 years of age. In this cross-sectional study, investigators collected demographic data and medical histories, as well as menstrual history in females, from the medical records of 56 patients with beta-thalassemia major. Patients were examined to determine their pubertal status and the standard deviation score for height for evaluation of short stature. For evaluation of glucose tolerance, a fasting blood glucose and oral glucose tolerance test were performed. Evidence for diabetes mellitus was based on American Diabetes Association and World Health Organization criteria. Serum levels of calcium, phosphorous, thyroid-stimulating hormone, free thyroxin, luteinizing hormone and follicular-stimulating hormone, and estradiol in girls and testosterone in boys were measured. The mean and standard deviation for age in the 56 patients [36 males and 20 females] was 15.62 +/- 4.44 years. Diabetes mellitus was present in 5 patients [8.9%], impaired fasting glucose was found in 16 patients [28.6%] and an impaired glucose tolerance test was found in 4 patients [7.1%]. Short stature [standard deviation score <-2] was seen in 25 [70%] boys and 14 [73%] girls. Impaired puberty was found in 40 patients [71%]. Hypocalcaemia and primary overt hypothyroidism were present in 23 [41%] and 9 patients [16%], respectively. Only eight patients [14.3%] had no endocrine abnormalities. Despite therapy with deferoxamine to treat iron overload, the risk of secondary endocrine dysfunction remained high. Hypogonadism was one of the most frequent endocrine complications. Impaired glucose tolerance, short stature, hypocalcemia, subclinical and overt hypothyroidism are also frequent


Sujets)
Humains , Mâle , Femelle , Études transversales , Diabète/épidémiologie , Troubles de la croissance/étiologie , Troubles gonadiques/étiologie , Surcharge en fer/étiologie , Surcharge en fer/traitement médicamenteux , Déferoxamine , Hypocalcémie/étiologie , Hypothyroïdie/étiologie , Chélateurs
11.
EMHJ-Eastern Mediterranean Health Journal. 2002; 8 (4-5): 490-495
Dans Anglais | IMEMR | ID: emr-158087

Résumé

Repeated blood transfusions in patients with thalassaemia subject them to peroxidative tissue injury by secondary iron overload. To study the relationship between iron overload and antioxidant micronutrient status among children with thalassaemia, we measured serum levels of vitamins A and E, zinc, selenium, and copper in 64 children with beta-thalassaemia major and 63 age- and sex-matched controls. All of these elements were significantly lower in the thalassaemic children compared with controls. There was a highly significant inverse correlation between serum ferritin and serum retinol levels, and significant inverse correlations between serum iron and retinol and between serum iron and selenium. Serum ferritin showed a significant positive correlation with duration of chelation and transfusion treatments. Ways are needed to counteract this oxidative damage and its deleterious effect on the prognosis of thalassaemia


Sujets)
Adolescent , Enfant , Femelle , Humains , Mâle , Antioxydants/métabolisme , Transfusion sanguine/effets indésirables , Études cas-témoins , Chélateurs , Enfant d'âge préscolaire , Cuivre/sang , Ferritines/sang , Surcharge en fer/étiologie , Micronutriments/déficit , Évaluation de l'état nutritionnel , État nutritionnel , Zinc/sang
12.
Rev. méd. Hosp. Säo Vicente de Paulo ; 11(26): 59-62, jan.-jun. 2000. ilus, tab
Article Dans Portugais | LILACS | ID: lil-285498

Résumé

Hemocromatose hereditária é o termo usado para identificar uma doença ligada ao complexo maior de histocompatibilidade humana, de herança genética, onde há um inapropriado aumento da absorção intestinal de ferro. Cirrose hepática, diabetes, artrite e cardiopatia são achados frequentes em pacientes com a doença estabelecida. Os autores relatam caso de paciente com essa enfermidade e fazem uma revisão na literatura especializada acerca de sua fisiopatologia, métodos diagnósticos e terapêutica


Sujets)
Humains , Mâle , Adulte , Hémochromatose/physiopathologie , Surcharge en fer/étiologie , Hémochromatose/complications , Hémochromatose/diagnostic , Hémochromatose/thérapie
SÉLECTION CITATIONS
Détails de la recherche